Viewing StudyNCT03042611

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 9:40 AM
Last Modification Date: 2024-10-26 @ 12:18 PM
Study NCT ID: NCT03042611
Status: COMPLETED
Last Update Posted: 2022-07-08
First Post: 2017-01-24
Brief Title: A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer
Sponsor: Elevar Therapeutics
Organization: Elevar Therapeutics
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Gastric Cancer
Gastric Adenocarcinoma
Keywords:
Name View
Gastric Cancer View
Gastric Adenocarcinoma View
Gastro-esophageal Cancer View
Gastro-esophageal Junction Cancer View
Stomach Cancer View
Tumor View
Oncology View
Antiangiogenesis View
Metastatic View